
Maxion Therapeutics
Ion channel and GPCR drug discovery using innovative KnotBody technology
About Maxion Therapeutics
Maxion Therapeutics is a biotechnology company that creates antibody-based drugs for diseases caused by ion channels and G protein-coupled receptors (GPCRs). These diseases include autoimmune conditions, chronic pain, and heart disease.
Legal Name
: Maxion Therapeutics
Headquarters
: Cambridge, UK
Business Model
:
Founding Date
: 1970
No. of Employees
: